Departments of Vascular Surgery of Zhongshan Hospital, Fudan University, Shanghai, China.
National Clinical Research Center for Interventional Medicine, Shanghai, China.
Vascular. 2024 Oct;32(5):1159-1167. doi: 10.1177/17085381231192852. Epub 2023 Jul 31.
Cell therapy has had satisfactory safety and efficacy outcomes for no-option critical limb ischaemia (NO-CLI) patients. In the current study, we aimed to compare the image quality of ischaemic lower limb blood vessels shown on volumetric CT-based time maximum intensity projection CT perfusion (t-MIP CTP) versus single-phase CTA (sCTA). We also tried to quantify the blood flow of the ischaemic lower extremity based on the t-MIP technique, not only to precisely show the dynamic change in blood flow from before to after cell therapy but also to detect any relationship between this change and patient prognosis.
A total of 31 patients with thromboangiitis obliterans (TAO)-induced NO-CLI who had been referred from the department of vascular surgery to undergo autologous stem cell transplantation into a single limb from January 2020 to March 2021 were prospectively enrolled in this study. Preoperative sCTA or t-MIP CTP and postoperative 1-month t-MIP CTP were performed in all patients. Clinical outcomes, including the 1-month ankle-brachial index (ABI) and 3-month CLI status, were also analysed. Image quality, including objective scores (attenuation, signal-to-noise ratio [SNR] and contrast-to-noise ratio [CNR]), subjective scores and collateral scores, was compared between preoperative sCTA and t-MIP CTP. Vascular volume was calculated as the total volume (mL) of lower limb arteries within the scanning range. All images and calculations were performed by 2 separate radiologists. Receiver operating characteristic curves were drawn to reveal the sensitivity and specificity of vascular volume and ABI in predicting prognosis.
Both sCTA and t-MIP CTP images exhibited good quality for diagnosis. t-MIP CTP images showed significantly higher attenuation, SNR and CNR in all arterial segments (popliteal artery, anterior tibial artery, posterior tibial artery and peroneal artery). In subjective and collateral score evaluations, t-MIP CTP images were also significantly better than sCTA images (both < .05). At 1 month after transplantation, both vascular volume and ABI showed significant improvement (both < .01). At 3 months after transplantation, 38.71% of patients (12/31) achieved CLI relief (Rutherford class < 4). Through the receiver operating characteristic (ROC) curve, the 1-month vascular volume increase ratio showed better ability to predict the 3-month prognosis (radiologist 1: AUC, 0.757; sensitivity, 0.750; specificity, 0.840; radiologist 2: AUC, 0.803; sensitivity, 0.500; specificity, 1.000) than the 1-month ABI increase ratio (AUC, 0.607; sensitivity, 0.230; specificity, 0.820) or 1-month ABI (AUC, 0.410; sensitivity, 0.080; specificity, 0.580).
t-MIP CTP showed significantly higher-quality images of ischaemic limb vascularity than sCTA. t-MIP CTP can reveal the anatomical information of collaterals more accurately, which is of great importance for NO-CLI patients undergoing cell transplantation. The 1-month vascular volume increase ratio can predict the 3-month prognosis more precisely on this basis.
细胞疗法已在无选择关键肢体缺血(NO-CLI)患者中取得了令人满意的安全性和疗效结果。在本研究中,我们旨在比较容积 CT 基于时间最大强度投影 CT 灌注(t-MIP CTP)与单相 CTA(sCTA)显示缺血下肢血管的图像质量。我们还尝试基于 t-MIP 技术定量测量缺血下肢的血流,不仅精确显示细胞治疗前后血流的动态变化,还检测这种变化与患者预后之间的任何关系。
前瞻性纳入 2020 年 1 月至 2021 年 3 月血管外科就诊拟行单肢自体干细胞移植的血栓闭塞性脉管炎(TAO)所致 NO-CLI 患者 31 例。所有患者均行术前 sCTA 或 t-MIP CTP 及术后 1 个月 t-MIP CTP。同时分析临床结局,包括术后 1 个月踝肱指数(ABI)和 3 个月 CLI 状况。比较术前 sCTA 与 t-MIP CTP 的图像质量,包括客观评分(衰减、信噪比 [SNR]和对比噪声比 [CNR])、主观评分和侧支评分。血管容积计算为扫描范围内下肢动脉的总容积(mL)。所有图像和计算均由 2 位独立的放射科医生进行。绘制受试者工作特征曲线,以揭示血管容积和 ABI 在预测预后方面的敏感性和特异性。
sCTA 和 t-MIP CTP 图像均能很好地诊断。t-MIP CTP 图像在所有动脉节段(腘动脉、胫前动脉、胫后动脉和腓动脉)的衰减、SNR 和 CNR 均显著增高。在主观和侧支评分评估中,t-MIP CTP 图像也明显优于 sCTA 图像(均<0.05)。移植后 1 个月,血管容积和 ABI 均显著改善(均<0.01)。移植后 3 个月,38.71%(12/31)的患者(Rutherford 分级<4)CLI 得到缓解。通过接收者操作特征(ROC)曲线,1 个月时血管容积增加率能够更好地预测 3 个月的预后(放射科医生 1:AUC,0.757;灵敏度,0.750;特异性,0.840;放射科医生 2:AUC,0.803;灵敏度,0.500;特异性,1.000),优于 1 个月 ABI 增加率(AUC,0.607;灵敏度,0.230;特异性,0.820)或 1 个月 ABI(AUC,0.410;灵敏度,0.080;特异性,0.580)。
t-MIP CTP 显示缺血肢体血管的图像质量明显优于 sCTA。t-MIP CTP 可以更准确地显示侧支的解剖信息,这对接受细胞移植的 NO-CLI 患者非常重要。在此基础上,1 个月时的血管容积增加率可以更准确地预测 3 个月的预后。